All data are based on the daily closing price as of February 24, 2025
o
Olympus
7733.TSE
13.62 USD
0.30
+2.25%
Overview
Last close
13.62 usd
Market cap
15.36B usd
52 week high
19.88 usd
52 week low
12.61 usd
Target price
19.88 usd
Valuation
P/E
24.8756
Forward P/E
21.5983
Price/Sales
2.3263
Price/Book Value
3.1454
Enterprise Value
15.47B usd
EV/Revenue
2.3458
EV/EBITDA
12.6504
Key financials
Revenue TTM
6.65B usd
Gross Profit TTM
4.46B usd
EBITDA TTM
1.34B usd
Earnings per Share
0.55 usd
Dividend
0.12 usd
Total assets
9.52B usd
Net debt
-2.69M usd
About
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.